Treatment
Treatment clinical trials
We’re tracking 8,469 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT07162675Recruiting
Step count and treatment response in breast cancer patients
This study looks at how your daily step count, measured by a smartwatch, relates to how well your breast cancer responds to treatment before surgery. It may help show if being more active during chemotherapy leads to better outcomes.
Ankara, YenimahalleAges 18 years+ - NCT07163208Recruiting
Laser therapy for headache from neck problems
This trial tests if different types of low-level laser light can help reduce headaches caused by neck issues. It is a non-invasive treatment option for people whose headaches have lasted at least three months.
Lahore, Punjab ProvinceAges 18–65 - NCT07163910RecruitingPhase 2
Homoharringtonine plus hormone therapy before prostate surgery
This trial tests whether adding a drug called homoharringtonine (a type of chemotherapy) to standard hormone therapy before prostate surgery can improve outcomes for men with certain stages of prostate cancer. It's for men who haven't had any previous treatment and plan to have their prostate removed.
Nanjing, JiangsuAges 18–85 - NCT07164183RecruitingPhase 3
Comparing two drugs for endometriosis pain relief
This study tests if a new drug called Indinol Forto works as well as the standard drug Visanne for reducing endometriosis-related pelvic pain. It is for women with surgically confirmed endometriosis who have regular cycles and moderate to severe pain.
Kazan'Ages 18–45 - NCT07165756Recruiting
My life journey: support for localized breast cancer patients
This trial tests if giving written information documents helps women with early-stage breast cancer understand their disease and treatments better. It focuses on support and education during medical treatment like chemotherapy.
Vandœuvre-lès-NancyAges 18 years+ - NCT07165769RecruitingPhase 2
ZGR combo for newly diagnosed spleen lymphoma with large cells
This trial tests a combination of three drugs (zanubrutinib, obinutuzumab, and lenalidomide) for people newly diagnosed with splenic B-cell lymphoma that has large cells (prominent nucleoli). The goal is to see if this drug combination is safe and effective.
Tianjin, Tianjin MunicipalityAges 18–80 - NCT07165834Recruiting
Sexuality after sexual trauma: a group therapy study
This study explores how a psychoeducational group can help people reclaim their sexuality after sexual trauma. It aims to understand the struggles and successes of healing in a supportive setting.
SkienAges 18–65 - NCT07165951RecruitingPhase 3
Study of new drug combo for first treatment of advanced pancreatic cancer
This trial tests a new combination of drugs (TQB2868 injection plus anlotinib capsules) compared to standard chemotherapy for people with pancreatic cancer that has spread to other parts of the body and has not been treated before.
Hefei, AnhuiAges 18–75 - NCT07166016Recruiting
Walking study for people with hammertoe and nerve damage
This study looks at how different treatments affect walking in people with hammertoe and nerve damage in their feet. It may help find better ways to improve foot function and comfort.
Harlingen, TexasAges Any age - NCT07166172Recruiting
Long-term outcomes after fetal surgery for severe CDH
This study follows pregnant women and their babies after a special fetal surgery (FETO) for severe diaphragmatic hernia (CDH). It aims to understand long-term health outcomes for both mother and child.
Baltimore, MarylandAges 18 years+ - NCT07166757RecruitingPhase 1/Phase 2
Study of XS411 for early-onset Parkinson's disease
This trial tests a new treatment called XS411 for people with early-onset Parkinson's disease (age 50 or younger at diagnosis). It is for those whose motor symptoms are not well controlled with standard medications and who may benefit from a neurosurgical procedure.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT07168200RecruitingPhase 3
Study of Adebrelimab with Chemoradiation for Advanced Cervical Cancer
This trial tests whether adding a new immunotherapy drug (adebrelimab) to standard chemoradiation helps treat locally advanced cervical cancer better than chemoradiation alone.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07168317RecruitingPhase 2
Study of tislelizumab plus other drugs for new AITL lymphoma
This trial tests a combination of five drugs for people newly diagnosed with a rare type of lymphoma called angioimmunoblastic T-cell lymphoma (AITL). The goal is to see if this treatment helps control the cancer.
Xuzhou, JiangsuAges 18 years+ - NCT07168772Recruiting
Probiotic for multiple sclerosis
This trial is testing if taking a probiotic supplement alongside current MS treatments can help people with relapsing-remitting MS (RRMS). It may be a way to improve gut health and possibly reduce inflammation.
Barcelona, BarcelonaAges 18–55 - NCT07169331RecruitingPhase 4
Zanubrutinib for newly diagnosed Waldenström macroglobulinemia
This trial tests a targeted therapy called zanubrutinib for people with newly diagnosed Waldenström macroglobulinemia. It aims to see if the drug is safe and effective in controlling the disease and improving symptoms.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07169474Recruiting
Thumb base joint replacement for arthritis
This trial tests a surgery that replaces the joint at the base of the thumb to treat arthritis pain. It may help if you have thumb arthritis that hasn't improved with nonsurgical treatments.
MontpellierAges 18 years+ - NCT07169409RecruitingPhase 1
Telehealth for opioid use disorder in vulnerable settings
This trial tests whether a telehealth program can help people with opioid use disorder get and stay on buprenorphine treatment. It aims to make care more accessible for those in vulnerable situations.
Portland, OregonAges 18 years+ - NCT07170007Recruiting
Physiotherapy after birth trauma for first-time mothers
This study tests a special physiotherapy program for first-time mothers who had a vaginal tear or episiotomy during childbirth. The goal is to see if it helps recovery better than standard care.
Ribeirão Preto, São PauloAges 18 years+ - NCT07170254Recruiting
A study of BD114 for HPV-16 related cervical high-grade precancer
This trial tests an experimental treatment called BD114 for women with a specific type of cervical precancer (CIN3) caused by HPV-16. The goal is to see if it can help clear the precancerous cells. You may be eligible if you are between 25 and 50, have no plans for future pregnancy, and meet certain health criteria.
ShanghaiAges 25–50 - NCT07170917RecruitingPhase 2
Testing a new drug for moderate to severe hidradenitis suppurativa
This trial tests a new drug called Brivekimig for people with moderate to severe hidradenitis suppurativa (HS) who have not gotten enough relief from oral antibiotics. The goal is to see if it can reduce abscesses and inflamed bumps.
Phoenix, ArizonaAges 18 years+ - NCT07170995RecruitingPhase 3
Study of SHR-8068 with adebrelimab and chemo for lung cancer
This trial tests a new combination of drugs (SHR-8068 plus adebrelimab and chemotherapy) against another approved combination for people with advanced non-small cell lung cancer who have not had treatment yet. The goal is to see which combination works better.
Jinan, ShandongAges 18–75 - NCT07171099RecruitingPhase 3
Cough medicine for young children with viral colds
This trial tests if a new cough syrup (Rengalin) helps children ages 6 months to 3 years with a dry cough from a viral cold. It aims to reduce cough severity and improve comfort for your child.
GatchinaAges 6 months–3 years - NCT07171554Recruiting
A test to find the best drugs for advanced colorectal cancer
This trial uses a special test to help choose which drugs might work best for you if you have metastatic colorectal cancer that has stopped responding to first treatment. The goal is to match you with a more effective next therapy.
Lørenskog, AkershusAges 18 years+ - NCT07171567RecruitingEarly Phase 1
Vacuum therapy for penile numbness
This early-phase trial tests whether vacuum therapy can help improve numbness or reduced sensation in the penis. It may be an option for men who have already discussed this issue with a urologist.
Ottawa, OntarioAges 18 years+
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,469 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.